Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation at the Credit Suisse 2013 Antibody Day
5/6/2013 9:33:01 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Reports Fourth Quarter and Fiscal 2012 Financial Results
3/7/2013 11:29:00 AM
More...
|
Positive Data From Celldex Therapeutics, Inc. (CLDX)'s Phase 1 Study of CDX-301 Support Initiation of Pilot Study in Hematopoietic Stem Cell Transplantation
2/14/2013 11:06:51 AM
More...
|
Celldex Therapeutics, Inc. (CLDX)’ CDX-301 Safely Mobilizes Hematopoietic Cells in Phase 1 Study; Future Development Planned
12/11/2012 9:56:42 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Targeted Drug Benefits Patients With Aggressive Breast Cancer
12/10/2012 7:12:40 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation at Oppenheimer Healthcare Conference
12/7/2012 10:00:18 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Announces Positive Three-Year Survival Data for Rindopepimut Phase 2 Clinical Program
11/16/2012 9:09:20 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation at Lazard Capital Markets Healthcare Conference
11/9/2012 10:54:21 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Data Presentation at the American Society of Hematology 54th Annual Meeting and Exposition
11/6/2012 8:43:36 AM
More...
|
Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Data Presentations at the Society for Neuro-Oncology 17th Annual Scientific Meeting and Education Day
11/5/2012 9:55:27 AM
More...
|
|